Faron awarded EUR 3.8 Million in Arbitration Case
Faron Pharmaceuticals Ltd. (“Faron”) Faron Announces EUR 3.8 Million Award in Arbitration Case Against Rentschler Biopharma SE Company announcement, November 9, 2021 at 02:00 AM (EDT) / 07:00 AM (BST) / 09:00 AM (EEST) Inside information TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces that the arbitration tribunal appointed by the Arbitration